Expeditors International of Wshngtn Inc vs Tempus AI — how do they compare? Expeditors International of Wshngtn Inc trades at $181 (market cap $23.24B), while Tempus AI trades at $54.68 (market cap $10.28B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 2.3× Tempus AI's market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| EXPD | TEM | |
|---|---|---|
Market Cap | $23.24B | $10.28B |
Sector | Industrials | Broad Market / Factor |
52-Week High | $178.22 | $103.25 |
52-Week Low | $111.37 | $42.37 |
Enterprise Value | $22.49B | $10.96B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
EXPD trades at $180.87, up 1.49% with strong technical momentum and bullish moving averages. The company demonstrates solid fundamentals with consistent earnings beats, posting Q1 2026 EPS of $1.71 versus $1.33 expected. Revenue grew to $11.07B in 2025 with a 7.48% net margin and impressive 36.59% ROE. Recent dividend of $0.81 reinforces shareholder returns while cash flow trends show operational strength.
Despite trading above the $161.50 consensus target, EXPD's earnings momentum and operational efficiency support continued upside potential. Key risks include analyst skepticism with only 12% buy ratings and overbought technical conditions. The stock's premium valuation requires sustained execution amid transportation industry challenges and economic uncertainties.
Tempus AI (TEM) trades at $55.62, down 5.1% over 24 hours, with a neutral technical signal and bullish moving average alignment. The company reported Q1 2026 revenue growth and an earnings beat, though it remains unprofitable with a net margin of -22.2%. Recent news highlights FDA clearances and partnerships, while analyst consensus is strongly positive with a $68.50 price target.
The outlook balances high-growth potential in AI-driven healthcare data against significant near-term losses. Investment opportunity lies in Tempus's unique data platform and expanding market reach, but risks include persistent cash burn and competitive pressures. Upside depends on achieving profitability and scaling high-margin segments.
Trailing returns across standard periods
Latest headlines on both assets
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →